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Hepatic lipase (HL) is an N-glycoprotein that acquires
triglyceridase activity somewhere during maturation
and secretion. To determine where and how HL becomes
activated, the effect of drugs that interfere with matu-
ration and intracellular transport of HL protein was
studied using freshly isolated rat hepatocytes. Carbonyl
cyanide m-chlorophenyl hydrazone (CCCP), castano-
spermine, monensin, and colchicin all inhibited secre-
tion of HL without affecting its specific enzyme activity.
The specific enzyme activity of intracellular HL was
decreased by 25–50% upon incubation with CCCP or
castanospermine, and increased 2-fold with monensin
and colchicin. Glucose trimming of HL protein was not
affected by CCCP, as indicated by digestion of immuno-
precipitates with jack bean a-mannosidase. Pulse label-
ing experiments with [35S]methionine indicated that
conversion of the 53-kDa precursor to the 58-kDa form,
nor the development of endoglycosidase H-resistance,
were essential for acquisition of enzyme activity. In su-
crose gradients, HL protein from secretion media sedi-
mented as a homogeneous band of about 5.8 S, whereas
HL protein from the cell lysates migrated as a broad
band extending from 5.8 S to more than 8 S. With both
sources, HL activity was exclusively associated with the
5.8 S HL protein form. We conclude that glucose trim-
ming of HL protein in the endoplasmic reticulum is not
sufficient for activation; full activation occurs during or
after transport from the endoplasmic reticulum to the
Golgi and is associated with a decrease in sedimentation
velocity.
Hepatic lipase (HL)1 is an extracellular enzyme present in
the liver of most vertebrates. The enzyme is synthesized and
secreted by liver parenchymal cells, and subsequently bound in
the space of Disse, where it plays an important role in plasma
lipoprotein metabolism (1–3). HL hydrolyzes phospholipids and
triacylglycerols present in high and intermediate density li-
poproteins, and facilitates the hepatic uptake of remnant par-
ticles (4–6) and of cholesterol(esters) carried in high density
lipoproteins (7, 8). In addition, HL may act as a ligand protein
for remnant binding to the liver (9). In humans, a low HL
activity is associated with an increased atherosclerotic risk (10,
11). When expressed in transgenic mice, human HL was shown
to markedly reduce the accumulation of aortic cholesterol (12).
HL may protect against development of premature atherosclero-
sis by contributing to reverse cholesterol transport and reducing
the number of atherogenic remnants in the circulation. Expres-
sion of HL in the liver is under hormonal and dietary control,
which may be exerted at the level of synthesis, intracellular
processing, secretion, extracellular binding, and internalization.
When studying the post-translational control of HL expres-
sion in suspensions of freshly isolated rat hepatocytes, we
noted that newly synthesized HL acquires catalytic activity
toward triacylglycerols somewhere along the secretory path-
way (13). First, the specific enzyme activity of intracellular HL
was 3–5-fold lower than that of secreted HL. Second, HL activ-
ity secreted by hepatocytes in the absence of protein de novo
synthesis was 5-fold higher than was accounted for by the fall
in the intracellular HL activity. Such an apparent activation
was also observed for human HL in the HepG2 hepatoma cell
line (14). HL is a glycoprotein bearing two (rat) to four (human)
asparagine-linked glycans (15–17). For the synthesis and se-
cretion of fully active HL, N-glycosylation is a prerequisite (18,
19). When glycosylation is prevented, either by tunicamycin or
by site-directed mutagenesis, inactive HL protein accumulates
intracellularly (16, 20). Along the secretory pathway, the N-
linked oligosaccharide chains are extensively processed. In rat
hepatocytes treated with castanospermine, a selective RER
glucosidase inhibitor which prevents secretion of newly synthe-
sized HL, inactive HL was present; upon removal of the inhib-
itor, the HL protein acquired catalytic activity and was se-
creted (13). These observations show that newly synthesized
HL protein becomes catalytically active during oligosaccharide
processing after the terminal glucose residues have been re-
moved by the glucosidases in the RER, and suggest that acti-
vation may be intimately linked to the glycosylation state of the
HL protein.
The presence of terminal glucoses on HL protein itself may
prevent the acquisition of catalytic activity. However, the glu-
cose residues on N-glycoproteins have recently been implicated
in the protein folding and quality control system of the RER,
which prevents malfolded proteins from reaching the Golgi (21,
22). It is possible therefore, that glucose trimming is only
required for transport of the newly synthesized HL out of the
RER and that activation occurs subsequently in a distal com-
partment of the secretory pathway. In line with this, inhibition
of the Golgi mannosidase I with 1-deoxymannojirimycin has no
effect on either activation or secretion of HL in rat hepatocytes
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(13, 19). This suggests that once the glucose residues have been
removed, activation and subsequent secretion proceed inde-
pendently of further oligosaccharide processing.
If glucose trimming in the RER is necessary for activation of
HL protein itself rather than for transport of newly synthesized
HL protein out of the RER, one would expect that inhibition of
the transport process leads to the intracellular accumulation of
active HL protein. The present study was performed to test this
possibility. We determined in which intracellular compartment
HL protein is activated, by using inhibitors that primarily
affect vesicular transport in the secretory pathway. CCCP,
monensin, and colchicin inhibit transport of glycoproteins from
the RER to the Golgi (23, 24), from medial- to trans-Golgi (25)
and between the Golgi and the plasma membrane (26, 27),
respectively. Our data show that active HL accumulates in
monensin- and colchicin-treated hepatocytes, but not in cells
treated with CCCP. Hence, glucose trimming alone does not
activate HL but is necessary for translocation of HL protein to
the Golgi compartment, where the protein apparently acquires
its triglyceridase activity.
EXPERIMENTAL PROCEDURES
Materials—Carbonyl cyanide m-chlorophenyl hydrazone (CCCP),
monensin, and ketoconazole were purchased from Calbiochem (La
Jolla, CA), whereas colchicin was from Merck (Darmstadt, Germany).
Castanospermine, 1-deoxymannojirimycin, jack bean a-D-mannoside
mannohydrolase (a-mannosidase), and CHAPS were from Roche Mo-
lecular Biochemicals (Germany). Endo-b-N-acetylglucosaminidase H
was from Genzyme (Boston, MA). Protease inhibitors were from Sigma,
except for Trasylol which was from Bayer (Mijdrecht, Holland).
Tran35S-label (1100 Ci/mmol) was obtained from ICN (Costa Mesa, CA),
and glycerol [1-14C]trioleate (50–80 mCi/mmol) was from Amersham
Pharmacia Biotech. Ham’s F-10 and methionine-free minimal essential
medium were purchased from Life Technologies, Inc. (Breda, Holland),
whereas bovine serum was from BioTrading (Wilnis, Holland). Heparin
was from Leo Pharmaceuticals (Weesp, Holland). Goat and rabbit an-
ti-HL antisera were raised against rat HL purified from liver heparin
perfusates according to Jensen and Bensadoun (28); from the antisera
partly purified IgG fractions were prepared by precipitation in 50%
saturated ammonium sulfate followed by 17% (w/v) Na2SO4, as de-
scribed previously (13). Alkaline phosphatase-conjugated goat anti-rab-
bit IgG was obtained from Tago (Burlingame, CA), and p-nitrophenol
phosphate was from Merck. Broad-range protein size markers were
from Bio-Rad. All other chemicals were from Sigma. Polystyrene 96-
well EIA plates (code 3590) were from Costar (Cambridge, MA).
Hepatocyte Isolation and Incubation—Hepatocytes were isolated
from male Wistar rats (200–250 g body weight) by collagenase perfu-
sion: non-parenchymal cells were removed by differential centrifuga-
tion (29). Cell viability was determined by trypan blue exclusion and
ranged from 85 to 90%. The cells were suspended at a density of 4 3 106
cells/ml in minimal essential medium containing 25 units/ml heparin
and 20% of dialyzed, heat-inactivated bovine serum (30). Cell suspen-
sions were incubated at 37 °C under an atmosphere of 5% CO2, 95% O2
in a shaking water bath. The incubations were started with the addition
of inhibitors. CCCP, monensin, and colchicin were added from 1000-fold
stock solutions in ethanol; other inhibitors were added from 100-fold
stocks in PBS. At the times indicated, samples of the cell suspension
were collected on ice. The cells were separated from the medium by
centrifugation for 5 s at 10,000 3 g. The cells were washed once in PBS
and then resuspended at 15 3 106 cells/ml in a 40 mM NH4OH buffer,
pH 8.1 (31), containing 25 units/ml heparin and a mixture of protease
inhibitors (1 mM EDTA, 10 units/ml Trasylol, 0.1 mM benzamidine, and
2 mg/ml each of leupeptin, antipain, chymostatin, and pepstatin). After
30 min on ice, the lysates were sonicated for 15 s (MSE Soniprep 150,
amplitude 14 mm) and centrifuged for 10 min at 10,000 3 g and 4 °C.
The supernatants were used for analysis of intracellular HL. Cell-free
media and cleared lysates were rapidly frozen in liquid nitrogen and
stored at 280 °C until use.
Hepatic Lipase Activity—Hepatic lipase activity was determined by a
triacylglycerol hydrolase assay at pH 8.5 in 0.6 M NaCl using a gum
acacia-stabilized glycerol [14C]trioleate emulsion as substrate (19). As-
says were performed for 30 min at 30 °C. Activities were expressed as
milliunits (nanomoles of free fatty acids released per min). In a total
assay volume of 125 ml, release of free fatty acids was linear with time
and sample volume up to 50 ml for the cell-free media and 10 ml for the
cell lysates.
In immuno-inhibition assays, 40 ml of the cell-free media or 10 ml of
the cell lysates were preincubated for 1 h on ice in a total volume of 50
ml with either 100 mg of goat non-immune IgGs or anti-rat HL IgGs.
Thereafter, 75 ml of substrate was added to the supernatant, and the
residual immunoresistant triglyceridase activity was determined. The
lipase activity in the extracellular media was completely inhibited by
the anti-HL IgGs whereas 85–95% of the lipase activity in the cell
lysates was sensitive to immuno-inhibition.
Hepatic Lipase Mass—The amount of HL protein was determined by
a solid-phase enzyme-linked immunosorbent assay in which the anti-
gen was sandwiched between goat and rabbit polyclonal anti-HL IgGs.
EIA plate wells were coated with 20 mg of goat anti-HL IgGs. After
blocking with 1% bovine serum albumin in PBS, the wells were incu-
bated successively with: (i) sample, either 50 ml of cell-free medium or
5 ml of cell lysate; (ii) 3 mg/ml rabbit anti-HL IgGs in PBS, and (iii)
alkaline phosphatase-conjugated goat anti-rabbit IgG at a 1:1500 dilu-
tion in PBS. Finally, the presence of alkaline phosphatase was detected
with p-nitrophenol phosphate as substrate. Color development was
stopped with NaOH (1 M, final concentration), and the absorbance at
405 nm was measured in a Molecular Devices microplate reader. Ab-
sorbances were read against a standard curve prepared for each plate
by serial dilutions of rat HL partly purified from liver heparin perfu-
sates by affinity chromatography on Sepharose-heparin; HL activity
was eluted from the column by a linear salt gradient and the peak
fractions were pooled. After adding bovine serum albumin to a final
concentration of 1%, aliquots were frozen in liquid nitrogen and stored
at 280 °C until use.
Pulse Labeling with [35S]Methionine—Freshly isolated rat hepato-
cytes were incubated in methionine-free minimal essential medium in
the absence or presence of inhibitors, as described above. After 1 h, 80
mCi of Tran35S-label was added per ml of cell suspension, and the
incubation was continued for the time indicated. The incubations were
stopped on ice, and the cells and media were separated by centrifuga-
tion (5 s, 10,000 3 g). The cell-free medium was collected in vials
containing cold methionine (final concentration 1 mM) and the mixture
of protease inhibitors described above. After washing twice with cold
PBS, the cells were lysed in cold PBS containing 1% Triton X-100, 1%
sodium deoxycholate, 0.25% SDS, 1 mM methionine, 25 units/ml hepa-
rin, 10 mM HEPES, pH 7.4, and the mixture of protease inhibitors. After
30 min on ice, the lysates were centrifuged for 10 min at 10,000 3 g and
4 °C, and the supernatants were used for further analysis.
Immunoprecipitations and Glycosidase Digestions—HL protein was
immunoprecipitated from cell-free media and cell lysates by overnight
incubation at 4 °C with 50 ml of a 50% slurry of goat anti-HL IgGs
immobilized onto Sepharose (13). The beads were collected by centrif-
ugation (20 s, 10,000 3 g), and washed twice in successively: (i) 1%
Triton X-100 in PBS, (ii) 1 M NaCl in PBS, and (iii) PBS (all containing
1 mM phenylmethylsulfonyl fluoride). For digestion with jack bean
a-mannosidase (JBAM), the beads were resuspended in 100 ml of a 50
mM sodium acetate buffer, pH 5.0, containing 5 mM Zn21, and then
incubated overnight with or without 50 mg of JBAM. Thereafter, the
immunoprecipitated proteins were released by boiling for 5 min in
Laemmli’s sample buffer without 2-mercaptoethanol, and the beads
were removed by centrifugation. After treating with 2-mercaptoethanol,
the released proteins were separated by SDS-PAGE using 7.5% gels.
For digestion with Endo-H, the immunoprecipitates were resuspended
in 50 mM NaPi, pH 6.0, containing 0.5% SDS, and the proteins were
released from the beads by boiling for 5 min. The eluate was diluted in
50 mM NaPi, pH 6.0, to reduce the concentration of SDS to 0.2%, and
then incubated overnight at 37 °C in the presence or absence of 40
milliunits/ml of Endo-H. After addition of Laemmli’s sample buffer and
boiling for 5 min, the proteins were separated by SDS-PAGE using 7.5%
gels.
After SDS-PAGE, the gels were Coomassie-stained for estimation of
molecular sizes. The 35S-labeled proteins were visualized, and their
radioactivity quantified, by exposure of the dried gels to a phosphor
screen (Bio-Rad GS-363 Molecular Imager System, Hercules, CA). Sen-
sitivity to JBAM or Endo-H was indicated by an increase in electro-
phoretic mobility.
Overall Protein de Novo Synthesis—Incorporation of [35S]methionine
into trichloroacetic acid-precipitable material was taken as a measure
for overall protein de novo synthesis. Incubations were performed as
described above. Of the cell-free media and lysates, 5-ml aliquots were
spotted in duplicate onto Whatman 3MM filters, and trichloroacetic
acid precipitation was performed as described previously (19). The
radioactivity on the filters was measured using the Molecular Imager
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System. The duplicate measurements, which never differed by more
than 5%, were averaged. The data were corrected for the trichloroacetic
acid-precipitable material in the media and lysates of a control cell
suspension that was put on ice before addition of Tran35S-label.
Sucrose Velocity Gradient Centrifugation—Hepatocytes were incu-
bated for 3 h with heparin, and cell-free medium was prepared as
described above. Cells were lysed in PBS containing 8 mM CHAPS, 25
units/ml heparin and the mixture of protease inhibitors. After 30 min on
ice, the lysates were cleared by centrifugation (10 min, 10,000 3 g,
4 °C). Of the secretion media and cleared lysates, 200-ml aliquots were
layered on top of linear 5–20% (w/w) sucrose gradients (4.0 ml) in 2 mM
MOPS buffer, pH 8.0, 4 mM CHAPS, and 25 units/ml heparin. The
gradients were run at 40,000 rpm for 15 h at 4 °C in a Beckman SW60
rotor (Beckman Instruments). Gradients were collected in 0.32-ml frac-
tions by aspiration from the bottom of the tubes. Total recovery of HL
activity from the sucrose gradients was 95 6 10 and 135 6 25%
(means 6 S.D., n 5 5) for secretion media and cell lysates, respectively.
The sedimentation markers bovine albumin (s20,w 5 4.3 S) and rabbit
IgG (s20,w 5 7 S) were run in parallel; their position in the sucrose
gradients was determined by Coomassie staining (32).
Statistics—All data are expressed as mean 6 S.D. Differences were
tested statistically by one-way analysis of variance followed by the Stu-
dent-Newman-Keuls test, and considered significant at p , 0.05 (33).
RESULTS
Effect of CCCP on HL Synthesis and Secretion—When
freshly isolated rat hepatocytes were incubated for 3 h in the
presence of heparin, HL activity in the cell lysates remained
almost constant at 4.3 6 1.3 milliunits/ml (n 5 6), which equals
0.27 6 0.08 milliunits/106 cells. During this incubation, HL
activity in the extracellular medium increased from 0.4 6 0.1 to
9.1 6 2.6 milliunits/ml, which corresponds to 2.3 6 0.6 milli-
units/106 cells. In the presence of increasing concentrations of
CCCP, the extracellular appearance of HL activity gradually
fell (Fig. 1A). Complete inhibition was obtained with 20 mM
CCCP and above. Intracellular HL activity decreased to 63 6
10% (n 5 3) of controls when cells were incubated with 10 mM
CCCP; a further increase in the CCCP concentration did not
have an additional effect on intracellular HL activity. To study
the effect of CCCP on de novo synthesis of HL protein, [35S]me-
thionine was included during the last hour of incubation. Fig.
1B shows that CCCP induced a dose-dependent reduction in
the 35S radioactivity of HL protein immunoprecipitated from
the media plus lysate (53 1 58 kDa bands; see below). This
parallelled the effect of the inhibitor on incorporation of 35S
radioactivity into trichloroacetic acid-precipitable material,
and hence on overall protein synthesis (not shown). With 20 mM
CCCP and above, HL and overall protein synthesis were com-
pletely blocked. When incubated with CCCP up till 10 mM,
[35S]HL in immunoprecipitates from the cell lysates was hardly
affected, whereas [35S]HL in the extracellular media was
highly sensitive to inhibition. With 10 mM CCCP, where HL
synthesis was reduced by approximately 30%, the newly syn-
thesized HL protein was no longer secreted into the extracel-
lular medium but remained in the cells.
Pulse-chase experiments were performed to study the effect
of CCCP on maturation of newly synthesized HL protein. After
a 5-min pulse with [35S]methionine, 35S-labeled HL migrated
as a 53-kDa protein (Fig. 2). During the subsequent chase of
control cells, the 53-kDa protein was converted into a 58-kDa
protein with a half-life of approximately 20 min. Pulse labeling
of cells that had been preincubated with 10 mM CCCP also
resulted in a 35S-labeled HL protein with apparent molecular
mass of 53 kDa. During the chase in the presence of CCCP, the
53-kDa HL protein matured into the 58-kDa form but at a much
lower rate. The 58-kDa form appeared only after 30 min chase;
approximately 50% of the 53-kDa form had matured into the
58-kDa form after 45 min of chase. The 53-kDa band was sensi-
tive to digestion with Endo-H, whereas the 58-kDa band was
Endo-H resistant (see below). Hence, CCCP retarded the matu-
ration of the 53 kDa, high-mannose type precursor form into the
58-kDa complex-type form of HL. Taken together, the effects of
CCCP on HL maturation and secretion are in agreement with
its proposed action as inhibitor of the RER-to-Golgi transport.
Comparison between Effects of CCCP and Castanosper-
mine—The effect of 10 mM CCCP on HL expression was com-
pared with that of 100 mg/ml castanospermine, which inhibits
RER-to-Golgi transport of N-glycoproteins by interfering with
oligosaccharide processing. After 3 h of incubation, both HL
FIG. 2. Effect of CCCP on HL maturation. Hepatocytes were
preincubated for 45 min with or without 10 mM CCCP. The cells were
pulsed for 5 min with [35S]methionine, and after washing, the cells were
chased in control medium (Con) or in medium containing 10 mM CCCP,
respectively. At the times indicated, samples were withdrawn and put
on ice. HL was immunoprecipitated from the whole cell suspensions and
analyzed by SDS-PAGE and PhosphorImaging. The apparent molecu-
lar weight of the bands is indicated in kDa.
FIG. 1. Effect of CCCP on synthesis and secretion of HL. Freshly isolated rat hepatocytes were incubated for 3 h in the presence of different
concentrations of CCCP. At the end of the incubation, the HL activity in the cell-free media (l ) and cell lysates (E) was measured (panel A). Data
are expressed as percentage of the activity found for the control incubation, which was 9.1 and 4.3 milliunits/ml in the cell-free medium and cell
lysate, respectively. In parallel incubations, 80 mCi/ml Tran35S-label was added after 1 h of preincubation with CCCP (panel B). The incubation
was continued for an additional hour and then cell-free media (f) and cell lysates (M) were prepared. HL protein was immunoprecipitated by
overnight incubation with goat anti-HL IgGs coupled to Sepharose. The immunoprecipitated proteins were separated by SDS-PAGE and the
radioactivity in the immunoreactive bands at the 53–58-kDa position in the gels were quantified by PhosphorImaging. The sum of the radioactivity
in the bands from the lysate and cell-free medium was taken as a measure for total synthesis of HL protein (). Data are expressed as percentage
of the radioactivity present in the corresponding bands from control media and lysate. The results are representative for two similar experiments.
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activity and HL protein were reduced in the extracellular me-
dium of CCCP-treated cells by approximately 85% compared
with controls, whereas with castanospermine, both parameters
were decreased in parallel by 65% (Table I). The specific en-
zyme activity of secreted HL was about 45 milliunits/mg, which
was not significantly affected by either treatment. Under the
conditions used, the specific enzyme activity of HL in the con-
trol cell lysates was only 50% of that in the cell-free media.
Upon treating the cells with CCCP, the amount of intracellular
HL protein was hardly affected, although simultaneously, HL
activity decreased by approximately 35% (Table I). Hence, the
specific enzyme activity of intracellular HL was 25% lower in
CCCP-treated cells than in control cells. In the presence of
CSP, both HL protein and HL activity in the cells were signif-
icantly reduced compared with controls, but the effect on HL
activity was stronger than on HL protein. As a result, the
specific enzyme activity of residual HL fell by approximately
50%. In parallel incubations, the effect of the inhibitors on
overall protein de novo synthesis was determined. Incorpora-
tion of [35S]methionine into total trichloroacetic acid-precipita-
ble material was reduced to 52.5 6 24.4 and 71.2 6 8.1% of
control by CCCP and CSP, respectively (n 5 3).
To test whether CCCP also interferes with oligosaccharide
processing in the RER, the glucose trimming status of the
glycan chains on newly synthesized HL protein was evaluated
with JBAM (34, 35). Digestion of high mannose-type glycopro-
teins with this exomannosidase will remove five mannose res-
idues from oligosaccharides bearing terminal glucose residues
(Glc1–3Man9GlcNAc2), but eight mannoses from completely
glucose-trimmed glycan chains (Man9GlcNAc2). The mobility of
the 35S-labeled 58-kDa HL protein band present in control cells
and secretion media, was not affected by incubation with
JBAM (Fig. 3), which agrees with the conclusion that this
protein reflects mature HL bearing complex-type oligosaccha-
rides. Upon digestion with JBAM, the 53-kDa band present in
the control cells was converted into two higher mobility bands
with apparent molecular masses of 52 and 49 kDa, which may
reflect HL protein with incompletely and fully glucose-trimmed
glycans, respectively. A similar digestion pattern was observed
for the 53-kDa 35S-labeled HL protein present in CCCP-treated
cells. In contrast, [35S]HL that is retained in CSP-treated cells
predominantly migrated as a 55-kDa band whose mobility was
increased to approximately 52 kDa upon treatment with
JBAM. These observations suggest that CCCP inhibits trans-
port of de novo synthesized HL protein out of the RER without
interfering with glucose trimming.
Effect of Monensin and Colchicin—In the presence of 50 mM
monensin, secretion of HL activity was instantaneously and
almost completely inhibited (Fig. 4A). After 2 h of incubation,
HL activity in the extracellular medium was 14 6 4% (n 5 4) of
parallel controls. Simultaneously, the intracellular HL activity
increased linearly with time to 250 6 44% (n 5 4) of control
cells (Fig. 4B). Under these conditions, [35S]methionine incor-
poration into total protein was 44.2 6 13.1% of control (n 5 3).
Half-maximal effects of monensin on extracellular and intra-
cellular HL activity were obtained with 5 6 2 mM (n 5 3), which
is much higher than the concentrations that inhibit transport
across the Golgi in other cell types. At this concentration,
secretion of HL activity was almost completely inhibited during
the first 60 min of incubation, but thereafter, secretion pro-
ceeded at a rate similar to that in untreated control suspen-
sions. With other concentrations of monensin, secretion of HL
activity also started after an initial inhibitory period; this lag
time increased with the amount of monensin used. Apparently,
in our suspensions of freshly isolated rat hepatocytes, monen-
sin loses its efficacy in a time- and dose-dependent manner.
Rapid detoxification of monensin has been shown to occur in
freshly isolated rat liver microsomes by the cytochrome P-450
3A system, where it can be inhibited by competing substrates
such as ketoconazole (36). When we co-incubated intact rat
hepatocytes with 25 mM ketoconazole, the dose-response curve
for monensin was shifted to markedly lower concentrations
(data not shown); half-maximal effects on HL secretion and
intracellular HL activity were now obtained with 0.3 6 0.1 mM
monensin (n 5 3). This effective dose suggests that monensin
affects HL secretion and intracellular HL activity through its
inhibitory effect on Golgi function. Due to its rapid detoxifica-
tion in freshly isolated rat hepatocytes, much higher concen-
trations of monensin are needed to maintain an effective dose
throughout the 2–3-h incubation period.
In the presence of 50 mM colchicin, the secretion rate of HL
FIG. 3. Evaluation of glucose trimming status of HL protein by
digestion with jack bean a-mannosidase. Hepatocytes were prein-
cubated for 45 min in the absence (Con) or presence of 10 mM CCCP or
100 mg/ml CSP, and then labeled for 30 min with [35S]methionine. After
immunoprecipitation from the cell free media (M) and from the cell
lysates (Cell), HL protein was incubated overnight without (2) or with
(1) JBAM. The proteins were then resolved by SDS-PAGE and ana-
lyzed by PhosphorImaging. The apparent molecular weight of the ra-
dioactive bands is indicated in kDa.
TABLE I
Effect of castanospermine and CCCP on intracellular and extracellular HL
Freshly isolated rat hepatocytes were incubated for 3 h in the presence of heparin without further additions (control), or with 10 mM CCCP or
100 mg/ml castanospermine (CSP). Then, cell-free media and cell lysates were assayed for HL activity and HL protein. Data are expressed as
mean 6 S.D. for three–five independent experiments.
HL activity HL protein Specific activity
Milliunits/ml % Microgram/ml % Milliunits/mg %
Cell-free media
Control 10.4 6 1.9 100 0.20 6 0.06 100 42.8 6 8.4 100
CCCP 1.4 6 1.1a 14 0.03 6 0.02a 15 40.1 6 15.4 94
CSP 3.4 6 0.6a 33 0.07 6 0.02a 37 44.5 6 12.8 104
Cell lysates
Control 4.8 6 2.1 100 0.22 6 0.07 100 23.1 6 10.5 100
CCCP 3.0 6 0.2b 63 0.21 6 0.10 94 17.7 6 1.3b 76
CSP 1.8 6 0.5b 36 0.13 6 0.04b 61 10.9 6 3.4b 47
a Statistically significant difference from control media (p , 0.05).
b Statistically significant difference from control lysates (p , 0.05).
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activity was reduced to 45 6 9% of controls (Fig. 4A), whereas
intracellular HL activity gradually increased to 236 6 34% of
controls (n 5 4) after 2 h of incubation (Fig. 4B). Protein de novo
synthesis was reduced to 71.7 6 16.6% of control (n 5 3).
Immuno-inhibition assays using anti-HL IgGs confirmed that
HL was responsible for the observed changes in intracellular
and secreted triglyceridase activity.
After 2 h of incubation with 50 mM monensin or colchicin, the
amount of HL protein in the extracellular medium was reduced
in parallel with HL activity, similar to the effects observed with
castanospermine and CCCP (Fig. 5A). In the cell lysates, the
amount of HL protein increased to 136 6 21 and 137 6 22% of
control values (n 5 4) with monensin and colchicin, respectively
(Fig. 5B). These increases in intracellular HL protein were sig-
nificantly less than the concomitant change in intracellular HL
activity (p , 0.05; n 5 4). As a result, the specific enzyme activity
of intracellular HL was increased with both inhibitors.
Specific Triglyceridase Activity of HL—The effects of the
different agents on the specific enzyme activity of HL are
summarized in Fig. 5C. Under all conditions, the specific en-
zyme activity of secreted HL remained constant at approxi-
mately 45 milliunits/mg of HL. In control cells, the specific
enzyme activity of intracellular HL was much lower than of
secreted HL. The specific activity was further reduced by 25
and 50% upon treating the cells with CCCP and castanosper-
mine, respectively. In monensin- and colchicin-treated cells,
the specific activity was increased to levels close to that of
secreted HL. In the presence of 1 mM 1-deoxymannojirimycin,
an inhibitor of Golgi mannosidase I, neither secretion of HL
(Fig. 5A) nor intracellular HL (Fig. 5B) were altered. Hence,
the specific enzyme activity of intracellular and secreted HL
was not affected (Fig. 5C) despite changes in the glycosylation
state of secreted HL (see below). Taken together, these obser-
vations suggest that the catalytic activity of HL increases upon
transport from the RER to the Golgi compartment.
Activation and Apparent Molecular Mass of HL—Hepato-
cytes were incubated for 3 h with the various inhibitors, and
[35S]methionine was present during the last 2 h. [35S]HL im-
munoprecipitated from control media migrated as a single
band of approximately 58 kDa (Fig. 6A). The 35S-labeled HL
secreted by CCCP- and colchicin-treated cells also migrated at
the position of 58 kDa, but the radioactivity was reduced to 35
and 17% of control, respectively. In the presence of monensin,
secretion of [35S]HL was decreased to 3% of control, and the
radioactive band migrated at a slightly higher mobility than
the 58-kDa band in the other secretion media (Fig. 6A). [35S]HL
immunoprecipitated from control lysates appeared as two
bands on SDS-PAGE, a band of approximately 53 kDa, and a
band of 58 kDa that co-migrated with [35S]HL from the cell-free
media (Fig. 6B). The total 35S radioactivity in HL immunopre-
cipitated from CCCP-treated cells was similar to control cells,
whereas in monensin- and colchicin-treated cells total 35S-
labeled HL was 2–2.5-fold higher. In lysates prepared from
CCCP-treated cells, the radioactivity of the 53-kDa band was
increased whereas that of the 58-kDa band was decreased (Fig.
6B). In colchicin-treated cells, the 35S label in the 53- and
58-kDa bands were increased in parallel. In contrast, the ac-
cumulation of [35S]HL radioactivity in the monensin-treated
cells only occurred in the 53-kDa band; in addition, the largest
band migrated at a mobility that was slightly higher than the
58-kDa band found in the other cells. Comparison of the data in
Fig. 6 with the effect of the inhibitors on intracellular and
secreted HL activity indicated that HL activity varied in par-
allel with the expression of the 58-kDa protein form, except for
FIG. 4. Effect of monensin and
colchicin on extracellular and intra-
cellular HL activity. Freshly isolated
rat hepatocytes were incubated in the ab-
sence (l ) or presence of 50 mM monensin
(f) or 50 mM colchicin (). At the indicated
times, aliquots of the cell suspension were
collected from the incubation, and HL ac-
tivity was measured in the cell-free media
(panel A) and cell lysates (panel B). Data
are representative for two similar
experiments.
FIG. 5. Effect of various inhibitors on intracellular and extra-
cellular HL activity and amount of HL protein. Hepatocytes were
incubated for 3 h in the absence (CON) or presence of 100 mg/ml CSP,
10 mM CCCP, 50 mM monensin (MON), 50 mM colchicin (COL), or 1 mM
1-deoxymannojirimycin (DMM). At the end of the incubation, cell-free
media (panel A) and cell lysates (panel B) were prepared and HL
activity (open bars) and the amount of HL protein (hatched bars) were
measured. Data are mean 6 S.D. for three to six experiments and are
expressed as percentage of control, which was 8.8 6 3.0 and 4.3 6 1.3
milliunits/ml for secreted and intracellular HL activity, and 0.19 6 0.05
and 0.18 6 0.03 mg/ml for secreted and intracellular HL protein, re-
spectively. Statistically significant differences from the corresponding
controls are indicated by asterisks (p , 0.05). In panel C, the specific
enzyme activity of HL in the extracellular medium (gray bars) and cell
lysate (closed bars) was calculated from the mean HL activity and HL
protein found for each condition in the medium and cell lysate,
respectively.
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the monensin-treated cells, where intracellular HL activity
increased in parallel with the 53-kDa protein form.
Activation and Resistance to Endoglycosidase H —The elec-
trophoretic mobility of [35S]HL secreted in the absence or pres-
ence of CCCP, monensin, or colchicin was not affected by over-
night incubation with Endo-H (Fig. 7A). Hence, secreted HL
was completely Endo-H resistant. As a reference, we used
[35S]HL that was secreted by cells in the presence of 1-deoxy-
mannojirimycin, which prevents the maturation of the N-gly-
cans from high-mannose to complex-type. This HL migrated as
a single 53-kDa band, the mobility of which was almost com-
pletely shifted to 47 kDa corresponding to deglycosylated HL
upon digestion with Endo-H (Fig. 7A). Of the two HL bands
immunoprecipitated from control cell lysates, the 58-kDa band
was Endo-H resistant whereas the 53-kDa band was sensitive
to Endo-H (Fig. 7B). Upon digestion, the 53-kDa band was
completely shifted to a higher mobility, partly to the position of
47 kDa, and partly to the position of a 51-kDa band. The
mobility of the latter band was not altered upon prolonged
incubation with additional Endo-H (not shown), and may re-
flect HL with one Endo-H-resistant and one Endo-H-sensitive
oligosaccharide. Similar results were obtained with [35S]HL in
lysates from CCCP- and colchicin-treated cells. With monen-
sin-treated cells, however, part of the [35S]HL migrating at the
53-kDa position was not shifted to a higher mobility upon
digestion with Endo-H and thus appeared to be Endo-H resist-
ant. These data suggest that the accumulation of intracellular
HL activity observed in monensin-treated cells coincides with the
production of a 53-kDa, mainly Endo-H resistant form of HL.
Oligomeric Structure and Catalytic Activity of HL—Since we
could not attribute the acquisition of catalytic activity to a
particular change in the glycosylation state of HL protein, we
attempted to correlate activation with possible noncovalent
modifications of HL. Recent reports have indicated that cata-
lytically active rat and human HL exist predominantly as non-
covalent homodimers (37, 38). We therefore determined the
oligomeric state of intracellular and secreted HL by monitoring
the sedimentation profile in sucrose gradients. Aliquots of cell
lysates and secretion media were loaded onto linear sucrose
gradients which were subjected to overnight ultracentrifuga-
tion. Preliminary experiments showed that heparin had to be
present throughout the gradients to prevent formation of large
HL containing aggregates with the secretion media, whereas
both heparin and CHAPS (4 mM) were necessary to prevent
aggregate formation with the cell lysates. When secretion me-
dia were run under these conditions, HL activity and HL pro-
tein sedimentated as a homogeneous band (Fig. 8, lower panel)
at a position intermediate between the sedimentation markers
albumin (4.3 S) and IgG (7 S). Partly purified HL from rat liver
perfusates ran at the same position (data not shown). The
sedimentation coefficient of this band was rougly estimated at
5.8 S, which is consistent with the dimeric structure of cata-
lytically active HL. No indications were found for the existence
of a separate population of HL protein in the 3 to 4 S region
corresponding to monomeric HL. The sedimentation profile of
HL activity from cell lysates was similar to that of secreted HL
(Fig. 8, upper panel), with a major band of about 5.8 S. In
contrast, HL protein sedimentated as a broad band that ex-
tended from the 5.8 S position to more than 8 S. HL activity
coincided with the slow-migrating part of HL protein, whereas
the fast-migrating part of HL protein was associated with very
low triglyceridase activity. The specific enzyme activity of the
5.8 S protein form in the cell lysate was approximately 40
milliunits/mg, compared with 50 milliunits/mg for the 5.8 S form
in the secretion media. The specific enzyme activity of the
faster-migrating protein forms in the cell lysate (fractions 4 to
6) ranged from 10 to 16 milliunits/mg. Also in the cell lysates,
FIG. 6. Effect of various inhibitors
on the electrophoretic mobility of
HL. Cells were incubated for 3 h in the
absence (CON) or presence of 10 mM
CCCP (CCCP), 50 mM monensin (MON),
or 50 mM colchicin (COL). During the last
2 h of the incubation, 80 mCi/ml Tran35S-
label was present. At the end of the incu-
bation, HL protein was immunoprecipi-
tated from the cell-free media and cell
lysates, and then analyzed by SDS-PAGE
and PhosphorImaging. The radioactivity
in the immunoreactive bands was quanti-
fied. Panels A and B show part of the
PhosphorImage and the quantitative re-
sults for the cell-free media and cell ly-
sates, respectively. The positions of the
58- and 53-kDa bands are indicated. In
panel B, the quantitative data for the 58-
and 53-kDa bands are given as upward
and downward bars, respectively. The re-
sults are representative for three similar
experiments.
FIG. 7. Effect of various inhibitors on the Endo-H sensitivity of
HL. Experiments were performed as described in the legend to Fig. 6,
except that prior to electrophoretic separation, the immunoprecipitated
proteins were incubated overnight at 37 °C without (2) or with (1)
Endo-H. As a positive control for Endo-H activity, a secretion medium
from a 3-h incubation of rat hepatocytes with 1 mM 1-deoxymannojiri-
mycin (DMM) was included. Panel A and B show the PhosphorImages
of the gels obtained with cell-free media and cell lysates, respectively.
The positions of the 58- and 53-kDa HL protein forms, as well as the
47-kDa deglycosylated form are indicated. Data are representative for
two similar experiments.
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the existence of a separate population of HL protein in the 3 to
4 S region corresponding to monomeric HL was not evident.
DISCUSSION
The data presented here confirm our previous report that
newly synthesized HL protein is apparently activated during
maturation and secretion in rat hepatocytes (13). This was also
observed for human HL in HepG2 cells (14). This activation
was prevented by treating the cells with inhibitors of RER
glucosidases, which interfere with proper oligosaccharide proc-
essing of the newly synthesized HL (13). Upon incubation with
castanospermine the specific enzyme activity of intracellular
HL decreased, which may suggest that activation is closely
coupled to glucose trimming in the RER. However, we show
here that a fall in the specific activity of intracellular HL was
also induced with CCCP, which interferes with transport of
glycoproteins out of the RER to the Golgi, but leaves oligosac-
charide processing in the RER essentially unaffected. Hence,
glucose trimming alone appears not to be sufficient for activa-
tion of HL, but is necessary for transport of HL out of the RER;
HL then matures into a catalytically active protein in a vesic-
ular compartment distal from the RER. The RER glucosidases
have been recently proposed to assist in the folding of newly
synthesized glycoproteins thereby making them transport com-
petent (21). In contrast to CCCP and castanospermine, a
marked increase in the specific enzyme activity of intracellular
HL was induced by treating the cells with monensin, which
interferes with intra-Golgi vesicular transport (25), as well as
with colchicin, which interferes with post-Golgi transport in rat
hepatocytes (26, 27). This finding clearly demonstrates that HL
has acquired full catalytic activity when accumulating in the
Golgi compartment. Our data are best explained by the model
that newly synthesized HL acquires catalytic activity during or
after transport out of the RER.
Lipoprotein lipase, which is closely related to hepatic lipase,
has also been shown to acquire catalytic activity after the
glucose residues of the glycan side chains have been removed.
Studies with monensin in mouse brown fat adipocytes (39) and
CCCP in 3T3-L1 adipocytes (40) led to the conclusion that LPL
is activated after transport of the protein from the RER into the
Golgi. This was supported by the observation that incubation of
adipocytes with brefeldin A, which induces the fusion of the
RER with the Golgi compartment, results in the intracellular
accumulation of fully active LPL (41). In our studies using
freshly isolated rat hepatocytes, maturation and secretion of
HL was not affected by brefeldin A (data not shown), possibly
due to the rapid detoxification of the drug by these cells (42). In
HepG2 cells, brefeldin A induced the intracellular accumula-
tion of catalytically active HL (14); moreover, the inactive HL
that accumulated in castanospermine-treated HepG2 cells was
converted to fully active HL upon co-incubation with brefeldin
A (14). These combined data suggest that both HL and LPL
require transport to the Golgi compartment to become catalyt-
ically active. In contrast, Ben-Zeev et al. (43) reported that LPL
accumulated intracellularly as a fully active enzyme when
expressed as a hybrid with a C-terminal KDEL sequence. As
this sequence was thought to function as an RER retention
signal, the authors concluded that activation of LPL does occur
before the protein reaches the Golgi compartment. Recent stud-
ies have demonstrated, however, that the KDEL sequence may
function as a retrieval signal; KDEL-bearing proteins are cy-
cled back into the RER from the Golgi or even beyond (44–46).
Therefore, the catalytically active LPL-KDEL hybrid that ac-
cumulates in the RER may have been activated in the Golgi
before being cycled back into the RER.
Our data indicate that catalytic activity co-varies with the
presence of the 58-kDa Endo-H resistant form of HL in CCCP
and colchicin-treated cells, and with the 53 kDa, mainly
Endo-H resistant form in monensin-treated cells. N-Glycopro-
teins are processed from an Endo-H sensitive into an Endo-H-
resistant form upon trimming of mannose residues by Golgi
mannosidases. These observations suggest therefore, that the
activation of HL is closely linked to, or occurs only after, some
of the mannoses on the glycan chains have been trimmed off by
the Golgi mannosidases. However, cells incubated with 1-de-
oxymannojirimycin secrete a 53 kDa, fully Endo-H sensitive
form of HL whose specific enzyme activity is virtually identical
to that of control HL (Fig. 7; Ref. 19). Therefore, trimming of
the oligosaccharides on HL by the Golgi mannosidases is not
crucial for the acquisition of triglyceridase activity. Taken to-
gether, these data demonstrate that activation of HL cannot be
attributed to a change in its glycosylation state detectable by
SDS-PAGE or Endo-H sensitivity.
Our observation that intracellular HL protein is present in
complexes with various sedimentation velocities, and that the
catalytic activity is associated with the slow-sedimenting pro-
tein forms suggests that activation of HL coincides with
changes in the oligomeric state of HL protein. Catalytically
active rat and human HL has recently been shown to exist
predominantly as noncovalent homodimers (37, 38). HL activ-
ity in both secretion media and cell lysates was linked to
protein forms that sedimented as approximately 5.8 S parti-
cles, which is consistent with the dimeric structure. We did not
find evidence for the existence of (inactive) HL in the 3–4 S
range corresponding to the monomeric protein. Instead, cell
lysates but not secretion media contained HL protein with low
FIG. 8. Sucrose gradient sedimentation profiles of intracellu-
lar and secreted HL. Hepatocytes were incubated for 3 h in the
presence of 25 units/ml heparin and 20% serum, and then cell-free
media and cell lysates were prepared. Aliquots of the cell-free media
(lower panel) and cell lysates (upper panel) were layered on top of a
linear 5–20% (w/w) sucrose gradient containing 25 units/ml heparin
and 4 mM CHAPS. After centrifugation, 13 fractions of the gradient
were recovered by aspiration from the bottom of the tube. HL activity
(closed symbols) and HL protein (open symbols) was measured for each
fraction. The position of bovine albumin (4.3 S) and rabbit IgG (7 S) in
parallel gradients is indicated by the arrows. The data are representa-
tive for three independent experiments.
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or no catalytic activity that predominantly sedimentated as
particles of 7 S and higher. This shows that (inactive) HL is
present in multimeric complexes, either as homo-oligomers or
with other proteins. Together with our previous observations
that inactive, intracellular HL protein can be secreted as active
HL in the absence of protein de novo synthesis (13, 14), these
findings suggest that activation of HL involves release of the
dimeric form from the larger complexes. Although the intracel-
lular localization of these multimer complexes is unknown at
present, it is tempting to speculate that they are present in the
RER. It is well established now that virtually all newly syn-
thesized N-glycoproteins temporarily associate with one or
more chaperone proteins that are abundant in the RER and
assist in their proper folding (21, 22, 47). CCCP blocks release
of endoplasmic reticulum proteins from their chaperones prob-
ably by depleting endoplasmic reticulum-ATP levels (48). Cas-
tanospermine interferes with proper glycoprotein folding (21,
22), thereby favoring formation of complexes with itself or with
other endoplasmic reticulum proteins. Transport of HL pro-
teins out of the RER will move them away from the numerous
RER chaperones that may block their full activation. Further
studies are required to establish the composition and intracel-
lular localization of the multimer complexes, and the precur-
sor-product relationship with the active HL dimers.
In conclusion, we have shown here that activation of newly
synthesized HL protein is associated with a change in the
oligomeric state of HL that occurs during or after transport
from the RER to the Golgi compartment. The necessity to exit
the RER in order to become activated is not unique to lipases,
but has recently also been reported for two membrane-bound
N-glycoproteins, the macrophage mannose receptor (49) and
the trans-Golgi network protease furin (50). The modification
that causes activation of these proteins has not been identified,
but was shown not to depend on oligosaccharide processing per
se. It may involve a rather subtle covalent modification not
detected by the rather course methods of SDS-PAGE and
Endo-H digestion. Alternatively, activation of these proteins
may be due to noncovalent changes in their structure, similar
to HL. Hence, our observations on the role of the oligomeric
state in activation of newly synthesized HL may bear relevance
to other proteins as well.
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